HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PFA UVA TEST DOSE RECIPROCITY SUPPORTED BY J&J STUDIES

This article was originally published in The Rose Sheet

Executive Summary

PFA UVA TEST DOSE RECIPROCITY SUPPORTED BY J&J STUDIES involving different light source irradiation levels, Johnson & Johnson Consumer Products Worldwide Applied Research Division research fellow Curtis Cole, PhD, told an FDA workshop on UVA testing methods May 12. "There are three separate sets of data that indicate that the protection factor in UVA (PFA) test obeys reciprocity," Cole said. Two of the studies have been published by J&J and the third is a pilot study.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000473

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel